Arkolith/Insider Trading/ZIVO/Form 4

Maggiore Christopher D.

Director, 10% OwnerZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Jun 6, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 5, 2024Grant(A)37K——373K
Jun 5, 2024Grant(A)82K$7.96$649K455K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 5, 2024Disposed to issuer(D)7K——0
Jun 5, 2024Disposed to issuer(D)3K——0
Jun 5, 2024Disposed to issuer(D)707——0
Jun 5, 2024Disposed to issuer(D)4K——0
Jun 5, 2024Disposed to issuer(D)2K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-24-007464) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML